[PLX] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
14-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 246.89%
YoY- 274.73%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 17,959 10,345 14,183 12,054 10,790 14,248 663 73.21%
PBT 3,843 -1,719 -3,567 -4,199 -4,437 -3,560 -15,544 -
Tax 607 133 442 96 118 34 230 17.53%
NP 3,236 -1,852 -4,009 -4,199 -4,437 -3,560 -15,544 -
Tax Rate -15.79% - - - - - - -
Total Cost 14,723 12,197 18,192 16,253 15,227 17,808 16,207 -1.58%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 18.02 -17.90 -28.27 -34.83 -41.12 -24.99 -2,344.49 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 0.04 -0.03 -0.08 -0.09 -0.14 -0.24 -1.05 -
EPS Diluted 0.04 -0.02 -0.08 -0.09 -0.14 -0.24 -1.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.